Voluntary ex ante transparency notice - Module for immunochemical analyses

as this is the only module on the market that is certified by NOKLUS for hcg as a cancer marker. A contract is planned to be signed with Roche Diagnostics Norway AS during August 2026. The competition is therefore impossible for technical reasons, as there is only one specific supplier who can de

liver, cf. foa paragraph 13-4 letter b second and third paragraphs. The procurement can be implemented without a competition.